Publications

Astellas to open new life sciences facility in DivcoWest’s Cambridge Crossing neighborhood
Transactions - AUGUST 11, 2023

To read this full article you need to be subscribed to Newsline.

Sign in Sign up for a FREE subscription

Astellas to open new life sciences facility in DivcoWest’s Cambridge Crossing neighborhood

by Released

Astellas Pharma and DivcoWest, a DivCore Capital Company, have plans for Astellas to open a new state-of-the-art life sciences facility at 441 Morgan Ave., in the Cambridge Crossing (CX) neighborhood in Cambridge, Mass. This investment establishes a significant presence for Astellas in one of the world’s premier life sciences innovation hubs, showcasing the company’s commitment to expanding its R&D footprint in order to accelerate innovation and deliver VALUE to patients.

441 Morgan is the fifth lab-ready building at CX and is situated at a gateway to the neighborhood with views of the Charles River and beyond. With wellness, connectivity and tenant experience at the forefront, when complete, 441 Morgan will offer five outdoor terraces, direct access

Forgot your username or password?